Browse By: Country ι Category ι Latest Reports ι Tag

Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019

Pages » 65
Published By » GlobalData
Price » $3995
In stock
View Report Details
Description

GlobalData, the industry analysis specialist, has released its new report, Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of information and analysis on the global Hepatitis A Preventive Vaccines market. The report identifies the key trends shaping and driving the global Hepatitis A Preventive Vaccines market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Hepatitis A Preventive Vaccines ... Click here for more details


Adult and Adolescent Vaccines Market to 2017 - Partnerships Increase as Licensing and Co-Development Account for 73% of all Deal-Making Activity in 2010
GBI Research, the leading business intelligence provider, has released its latest research, Adult and Adolescent Vaccines Market to 2017 - Partnerships Increase as Licensing and Co-Development Account for 73% of all Deal-Making Activity in 2010, which provides insights into the global vacc
Published Date: Aug 2011
Price: $3500
Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline to Shape the Future Cancer Vaccines Market
GBI Research, the leading business intelligence provider, has released its latest research, Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline to Shape the Future Cancer Vaccines Market, which provides insights into the global emerging c
Published Date: Oct 2011
Price: $3500
Vaccines - Africa
This package contains 4 vaccine market analyses from the following African countries: Ethiopia, Ghana, Morocco and Nigeria The vaccine market analyses give an overview of the actual situation, trends and future outlook of the vaccine markets in different African countries. The market ana
Published Date: Aug 2011
Price: $2018
Vaccines - America
This package contains 10 vaccine market analyses from the following American countries:  Canada, Chile, Colombia, Ecuador, Eritrea, Mexico, Panama, Peru, United States and Uruguay. The vaccine market analyses give an overview of the actual situation, trends and future outlook of the v
Published Date: Aug 2011
Price: $5269
Vaccines - Asia
This package contains 19 vaccine market analyses from the following Asian countries: Armenia, Azerbaijan, China, Georgia, India, Indonesia, Iran, Japan, Jordan, Kazakhstan, Kyrgyzstan, Malaysia, Oman, Pakistan, Singapore, South Korea, Sri Lanka, Thailand and Turkey. The vaccine market
Published Date: Aug 2011
Price: $10009
Vaccines - Eastern Europe
This package contains 15 vaccine market analyses from the following Eastern European countries:  Bulgaria, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Macedonia, Moldova, Poland and Ukraine The vaccine market analyses give an overview of the actual situation, tren
Published Date: Aug 2011
Price: $7842
Vaccines - Europe
This package contains 29 vaccine market analyses from the following European countries: Austria, Belgium, Bulgaria, Czech Republic,Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Macedonia, Moldova, the Netherlands, Norway, Poland, Portugal,
Published Date: Aug 2011
Price: $13396
Vaccines - Global
This package contains 63 vaccine market analyses from the following countries:  Austria, Belgium, Bulgaria, Czech Republic,Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Macedonia, Moldova, the Netherlands, Norway, Poland, Portugal, Ro
Published Date: Aug 2011
Price: $27076
Vaccines - Western Europe
This package contains 14 vaccine market analyses from the following Western European countries:  Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden and United Kingdom. The vaccine market analyses give an overview of th
Published Date: Aug 2011
Price: $7301
Vaccine Partnering Terms and Agreements
The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms an
Published Date: Jul 2014
Price: $2995

 


 

Related News

Global Paracetamol and PAP Market Fights an Uphill Battle
Paracetamol has been one of the most commonly used drugs in modern medicine. It has been used in the treatment of the most common ailments, including fever, cold, arthritis, and also major epidemics such as the swine flu. Consumers have shown a high rate of consumption of paracetamol as it provides almost instant relief from symptoms, is available everywhere as a generic drug, and is available as an over the counter drug in most countries. This includes the nations in North America, where the co
Date: Feb 18

Next-generation Antifungal Drugs Hold Promise for Dermatophytoses, Newer Therapeutics Overcome Shortcomings of Early Drugs
In the U.S., onychomycosis poses as a major public health problem, as it is prevalent in 10% of the population and its associated morbidity. Although not life-threatening, the fungal infection is a dermatophytic invasion of the nail plate. The infection can be present in any component of the nail unit, which includes the bed, matrix, or plate. Pain, discomfort, and disfigurement are the notable signs of onychomycosis, which may lead to significant physical and occupational limitations. The condi
Date: Jan 25

Despite Rise in Number of Erectile Dysfunction Cases, Revenue Generation from ED Drugs to Decline
This is probably one of the few times when availability of certain drugs is actually hampering the growth of a certain section of the health care market. The erectile dysfunction drugs market, over the past few decades, has been driven by the rising incidence of erectile dysfunction caused by environmental and genetic factors. However, there are several forces in the coming years that are anticipated to negatively impact the erectile dysfunction drugs market, causing it to register a -4.50 per c
Date: Jan 22

Chipotle and Costco E.coli Outbreaks Point out the Need for Advanced Testing Kit
During the period from October 2015 to November 2015, over 50 customers have been affected with E.coli after eating at Chipotle locations across Washington, Kansas, Oregon, and Oklahoma. More recently, 80 college students in Boston fell sick with the norovirus after contracting it from a single Chipotle location. By the end of 2015, more than 350 people became sick after eating at Chipotle. In early November, just after the Chipotle case had made headlines, another E.coli outbreak was reported i
Date: Jan 20

What the Newly Found Ebola Antibodies Mean for the Healthcare Industry
In what could be perceived to be one of the greater breakthroughs in the field of medicine, researchers have engineered the first antibodies that have the ability to neutralize two strains of the deadly Ebola-causing virus. The research was conducted on mice and is considered to be a major step in achieving immunization against all strains of Ebola. The research was led by Dr. Jonathan Lai. He stated that it is a tremendous advance to achieve a broadly effective Ebola immunotherapy. This is bec
Date: Jan 14

California Considering Exempting ‘Tampon Tax’
Growing awareness towards sanitation and urbanization has boosted the demand from the global feminine hygiene products market. In regions, especially Asia Pacific, several health programs focussed to raise awareness about sanitation across rural areas has augmented the market growth. Key market players such as Proctor & Gamble and Johnson & Johnson have partnered with governments in countries such as India to increase awareness among women regarding menstruation related health concerns. Rising c
Date: Jan 12

Aurobindo Pharma Latest to Join Line of Generic Drug Makers of Norethindrone Acetate
The United States Food and Drugs Association has officially given the nod of approval to Aurobindo Pharma to manufacture, sell, and market generic variants of norethindrone acetate within the U.S. market. The U.S. health regulator has provided Aurobindo Pharma with the vital agreement to create 5 mg strength tablets of norethindrone acetate, as said by an Aurobindo Pharma spokesperson in a recent statement. They later added that the drug has an estimated market size of US$42 mn for the twelve m
Date: Jan 11

Oral Contraceptive Pills Market Witnessing Surging Demand Particularly from Developed Regions
The market segment of oral contraceptive pills in the pharmaceutical industry is gearing to exhibit an exponential growth in the near future. The latest market studies published reveal promising growth prospects for the niche is very promising particularly due to the rising awareness about the pregnancy preventive methods, their corresponding benefits, and favorable reimbursement policies introduced by the policy makers.  Among the most prominent brands available in the market Loestrin and Bay
Date: Jan 07

Healthcare Bodies Apprehensive about Rising Popularity of E-cigarettes
E-cigarettes are nothing new to the world nowadays. These battery-operated devices, which emit vaporized nicotine or other flavored solutions, were marketed as safer alternative to conventional cigarettes as they purged the other harmful chemicals that a tobacco-based cigarette produced. It is widely known that tobacco smoke contains more than 4,000 different chemicals, many of which are very harmful for human health. When e-cigarettes first came to the market, they came with the promise of cutt
Date: Jan 06

Eli Lily’s New Diabetes Medicine Sees Rising Popularity; Tough Times ahead for Johnson & Johnson and AstraZeneca
The immensely competitive global pharmaceuticals industry is a battleground of multinational pharmaceutical companies who pour-in millions and billions worth of funds every years for the research and development of novel medications. The fear of novel medications being brought-in in the form of cheaper generics constantly haunts these companies, as does the fear of being downtrodden by innovative new alternatives being continuously flooded in the market that eat shares of old and once popular me
Date: Jan 06

Upcoming Reports

DNA Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019
Vaccines have been in use since decades to provide immunological responses against diseases. A conventional vaccine is a biological preparation of weakened or attenuated, killed forms of a microbe or one of its cellular components, while a DNA vaccine is composed of genetically engineered DNA. Whe
Published By: Transparency
Price: $4795
HPV Therapeutic Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers
Published By: Transparency
Price: $4795
Preventable Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
The use of preventable vaccines is to avoid the occurrence of an infectious disease, which is preventable by the use of vaccines. The occurrence of death due to a vaccine-preventable disease is termed as vaccine-preventable death, the reason being failure to attain vaccines in time, lack of access t
Published By: Transparency
Price: $4795